Cargando…
BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosine kinase overexpressed in more that 60% of human breast carcinomas. The overexpression of BRK has been shown to sensitize mammary epithelial cells to mitogenic signaling and to promote cell proliferat...
Autores principales: | Miah, Sayem, Goel, Raghuveera Kumar, Dai, Chenlu, Kalra, Natasha, Beaton-Brown, Erika, Bagu, Edward T., Bonham, Keith, Lukong, Kiven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921129/ https://www.ncbi.nlm.nih.gov/pubmed/24523872 http://dx.doi.org/10.1371/journal.pone.0087684 |
Ejemplares similares
-
Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation
por: Bagu, Edward T., et al.
Publicado: (2017) -
Correction: BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration
Publicado: (2014) -
FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition
por: Ogunbolude, Yetunde, et al.
Publicado: (2017) -
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
por: Miah, Sayem, et al.
Publicado: (2019) -
BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential
por: Miah, S., et al.
Publicado: (2019)